bumetanide has been researched along with Menopause in 1 studies
Menopause: The last menstrual period. Permanent cessation of menses (MENSTRUATION) is usually defined after 6 to 12 months of AMENORRHEA in a woman over 45 years of age. In the United States, menopause generally occurs in women between 48 and 55 years of age.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rejnmark, L | 1 |
| Vestergaard, P | 1 |
| Heickendorff, L | 1 |
| Andreasen, F | 1 |
| Mosekilde, L | 1 |
1 trial available for bumetanide and Menopause
| Article | Year |
|---|---|
Effects of thiazide- and loop-diuretics, alone or in combination, on calcitropic hormones and biochemical bone markers: a randomized controlled study.
Topics: Aged; Bendroflumethiazide; Biomarkers; Bone and Bones; Bumetanide; Calcitriol; Diuretics; Female; Hu | 2001 |